Clinical Trial for the Evaluation of Customized 3D Printed NIV Nasal Masks in Premature Infants

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age0-30
SponsorHospital Universitario 12 de Octubre

About this trial

Clinical trial with crossed groups, open, masked for the evaluation of the main outcome. Inclusion of all premature infants with a birth weight less than 1500 g requiring Non-invasive Ventilation (NIV).

Premature will be randomised to start alternatively with MT or 3DM. Each patient included will be their own control at the same time, receiving each of the different mask models every 4 hours alternately. The study period will be a maximum of 7 days.

To compare the time in which preterm maintain SatO2 below 85% with the 3DM versus the traditional mask (TM) in preterm \< 1500 g. Other secondary objectives regarding ventilation enhancement will be assessed, such as the number of bradycardias, cardiorespiratory arrest and need for resuscitation in the context of apnea. Also, skin lesions of the nose resulting from the pressure applied by any of the masks (TM or 3DM) and the need for analgesia and/or sedation for pain control or discomfort will be assessed. Parental perception and satisfaction will be assessed.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Newborn prematurity

Age: less than 30 days of life

Required respiratory support with non-invasive ventilation (NIV)

Premature infant has not been on NIV for more than 3 days before being included in the trial.

Disqualifiers

Failure to meet entry criteria

Cyanotic congenital heart disease diagnosis

Presence of serious malformations

Presence of airway malformations

Trial design

Design model

Crossover

Treatments tested in this trial

  • Custom 3D mask (3DM) application in neonate

    Device

    Premature infants with a birth weight less than 1500 g r first received 3D mask during 4 hour, then crossed over to traditional mask.

  • Traditional mask (TM) application in neonate

    Device

    Premature infants with a birth weight less than 1500 g r first received traditional mask during 4 hours, then crossed over to 3D mask.

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: 3D Mask (3DM)Experimental treatment 2 interventions
Group B: Traditional Mask (TM)Active comparator 2 interventions

Trial outcomes

Primary outcomes

1

Time in which preterm maintain SatO2 below 85%.

To compare the time in which preterm maintain SatO2 below 85%.in the period of time that customized 3D printed nasal mask (3DM) is used versus traditional nasal mask (TM).

Time frame
7 days

Secondary outcomes

1

Time in which preterm maintain bradycardias.

To compare the time in which preterm maintain bradycardias - heart rate below 100 beats per minute - that occur in the period of time that customized 3D printed nasal mask (3DM) is used versus traditional nasal mask (TM).

Time frame
7 days
2

Time in which preterm maintain SatO2 below 75%.

To compare the time in which preterm maintain SatO2 below 75%.in the period of time that customized 3D printed nasal mask (3DM) is used versus traditional nasal mask (TM).

Time frame
7 days
3

Number of times requiring cardiopulmonary resuscitation

Compare the number of times requiring cardiorespiratory resuscitation with self-inflating bag in the context of apnea pause or severe desaturation in the period of time that customized 3D printed nasal mask (3DM) is used versus traditional nasal mask (TM).

Time frame
7 days
4

Appearance of cutaneous lesions in nasal region or mucosa

To compare the appearance of cutaneous lesions in the nasal region or nasal mucosa as a consequence of the pressure exerted by any of the masks, indicating the location and degree of the wound in the period of time that customized 3D printed nasal mask (3DM) is used versus traditional nasal mask (TM).

Time frame
7 days

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.